Treatment: Treatment is supportive. Underlying infections need to be treated adequately. The main goals are pain control and prevention of secondary infection. If the patient’s neutrophilic eccrine hidradenitis is caused to a chemotherapeutic agent, a change in the chemotherapy regimen can be considered. If the patient’s chemotherapy cannot be changed, topical corticosteroids and nonsteroidal antiinflammatory agents may be used. If this is unsuccessful, dapsone and colchicine may be considered because of their antineutrophilic effects. Oral steroids have been used with variable success. No placebo-controlled studies have been performed for this condition.
Related posts:
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
